BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vijayakumar S, Finney John S, Nusbaum RJ, Ferguson MR, Cirillo JD, Olaleye O, Endsley JJ. In vitro model of mycobacteria and HIV-1 co-infection for drug discovery. Tuberculosis (Edinb) 2013;93 Suppl:S66-70. [PMID: 24388652 DOI: 10.1016/S1472-9792(13)70013-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Rampacci E, Stefanetti V, Passamonti F, Henao-Tamayo M. Preclinical Models of Nontuberculous Mycobacteria Infection for Early Drug Discovery and Vaccine Research. Pathogens 2020;9:E641. [PMID: 32781698 DOI: 10.3390/pathogens9080641] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Ren XX, Ma L, Sun WW, Kuang WD, Li TS, Jin X, Wang JH. Dendritic cells maturated by co-culturing with HIV-1 latently infected Jurkat T cells or stimulating with AIDS-associated pathogens secrete TNF-α to reactivate HIV-1 from latency. Virulence 2017;8:1732-43. [PMID: 28762863 DOI: 10.1080/21505594.2017.1356535] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
3 Fan X, Xu J, Files M, Cirillo JD, Endsley JJ, Zhou J, Endsley MA. Dual activity of niclosamide to suppress replication of integrated HIV-1 and Mycobacterium tuberculosis (Beijing). Tuberculosis (Edinb) 2019;116S:S28-33. [PMID: 31080089 DOI: 10.1016/j.tube.2019.04.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]